Peak6 Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

A detailed history of Peak6 Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 3,800 shares of REGN stock, worth $2.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,800

Previous 5,500 30.91%

Holding current value

$2.88 Million

Previous $5.78 Million 30.9%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $902 - $993	1 Added 100.0%	2 $1,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $1,550 - $1,763	-2 Reduced 66.67%	1 $0
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $692 - $844	1 Added 50.0%	3 $2,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $700 - $830	-1 Reduced 33.33%	2 $1,000
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $308,942 - $375,444	-454 Reduced 99.34%	3 $2,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $319,768 - $347,174	453 Added 11325.0%	457 $330,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $8.19 Million - $10.3 Million	-14,277 Reduced 99.97%	4 $2,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $7.83 Million - $10.5 Million	14,279 Added 713950.0%	14,281 $8.44 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $5.2 Million - $6.11 Million	-8,744 Reduced 99.98%	2 $1,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $1.15 Million - $1.43 Million	-2,124 Reduced 19.54%	8,746 $5.52 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $5.56 Million - $6.6 Million	9,690 Added 821.19%	10,870 $6.58 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $11.9 Million - $14.1 Million	-25,169 Reduced 95.52%	1,180 $659,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $11 Million - $13.5 Million	24,647 Added 1448.12%	26,349 $12.5 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $1.46 Million - $1.85 Million	-3,048 Reduced 64.17%	1,702 $822,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $9.16 Million - $10.7 Million	-33,511 Reduced 87.59%	4,750 $1.32 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $10 Million - $13.9 Million	33,447 Added 694.79%	38,261 $12 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $2.82 Million - $3.33 Million	-7,571 Reduced 61.13%	4,814 $1.98 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $4.16 Million - $4.99 Million	12,385 New	12,385 $4.63 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account

Peak6 Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History